We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

By HospiMedica International staff writers
Posted on 20 Jun 2025

More than 80% of in-hospital patients receive intravenous (IV) therapy. More...

Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure that no residual medicine is left in the IV set and that patients receive the full dose of medicine. Automated IV flushing is gaining increased recognition in clinical settings, especially in areas where accurate medication dosing is critical. Yet no streamlined, automatic solutions currently exist. Nurses are often burdened with time-consuming manual flushing procedures that introduce variability and increase the risk of error. Now, an automatic IV-line flushing device addresses a critical need among nurses, who currently spend significant time manually flushing IV lines to clear residual medication.

Droplet IV (Copenhagen, Denmark) has developed a unique and proprietary automatic IV line flushing device that is free from electronics, buttons, or breakaway seals. The revolutionary automatic IV-line flushing device automatically flushes the IV line when the IV medication bag is empty. This user-friendly solution consists is a prefilled flushing automation device that uses basic fluid dynamics principles to help patients receive full dosages. Designed for ease of use, it integrates seamlessly with existing IV bags and lines and is assembled at the start of each IV medication administration. This solution relieves nurses from the stress and time-sensitive task of manual flushing, which is often delayed and requires multiple checkups to confirm medication completion.

Droplet IV helps patients to receive the remaining ≈20% of the prescribed drug, which is trapped inside the IV line. This eliminates underdosing, which can lead to insufficient treatment and possible treatment failure. The issue is particularly significant for infusions of less than 250 mL, which constitute 89% of all infusions. Medicine left in IV lines contributes to expensive clinical waste and antimicrobial resistance (AMR), which is predicted to cause 10 million deaths and USD 1.2 trillion in health expenditures annually by 2050. By assisting in the full delivery of medication to patients, Droplet IV also prevents medicine from being discarded in the environment. Droplet IV’s unique and proprietary automatic IV line flushing device, which has received its ISO 13485 certification, is set to be launched in the EU and US in 2026.

Related Links:
Droplet IV


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
New
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Schematic of approach to simulating brain shunt fluid dynamics (Photo courtesy of Haritosh Patel/Harvard SEAS)

Computational Model Accurately Simulates Shunt Performance to Prevent Repeat Surgeries

Millions of people worldwide suffer from hydrocephalus, a condition characterized by the buildup of excess cerebrospinal fluid in the brain. Treatment typically involves the surgical placement of shunts... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.